Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in ABBV — AbbVie Inc.

CIK 70858 CHARLOTTE, NC
Back to ABBV Full portfolio

Position in ABBV

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$5,206,045,728
-$694,571,197 QoQ
Shares Held
23,936,943
-7.3% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 28.274646432503936.ToString("F0")% Shared 0.ToString("F0")% None 71.72535356749606.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Sep 30, 2025
CallValue
$287,642,142
CallShares
1,242,300
PutValue
$215,146,968
PutShares
929,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $38,990,456,692 across 16 Drug Manufacturers - General names. ABBV ranks #3 (13.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 11,125,832 $10,233,206,495
2 JNJ
Johnson & Johnson
 25,516,697 $6,237,301,411
3 ABBV
AbbVie Inc.
This page 		23,936,943 $5,206,045,728
4 AZN
Astrazeneca PLC
 19,058,327 $3,758,683,247
5 MRK
Merck & Co., Inc.
 30,774,221 $3,701,831,041
6 GILD
Gilead Sciences, Inc.
 19,978,936 $2,784,464,307
7 BMY
Bristol Myers Squibb Co
 32,586,981 $1,976,400,394
8 AMGN
Amgen Inc
 5,121,028 $1,801,833,698

All Filings in ABBV

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,206,045,728 23,936,943
2025-12-31 $5,900,616,925 25,824,399
2025-09-30 $5,824,366,701 25,154,905
2025-09-30 $215,146,968 929,200
2025-09-30 $287,642,142 1,242,300
2025-06-30 $62,331,196 335,800
2025-06-30 $4,660,852,299 25,109,645
2025-06-30 $86,090,556 463,800
2025-03-31 $5,856,823,600 27,953,530
2025-03-31 $166,547,448 794,900
2025-03-31 $115,843,608 552,900
2024-12-31 $92,315,150 519,500
2024-12-31 $119,290,010 671,300
2024-12-31 $4,500,068,577 25,323,965
2024-09-30 $4,135,362,126 20,940,663
2024-09-30 $140,704,500 712,500
2024-09-30 $81,381,508 412,100
2024-06-30 $71,455,232 416,600
2024-06-30 $3,540,130,945 20,639,756
2024-06-30 $70,666,240 412,000
2024-03-31 $3,591,837,818 19,724,535
2024-03-31 $82,837,290 454,900
2024-03-31 $134,353,380 737,800
2023-12-31 $2,882,434,712 18,599,953
2023-12-31 $113,019,621 729,300
2023-12-31 $135,505,768 874,400
2023-09-30 $2,861,290,915 19,195,565
2023-09-30 $86,499,518 580,300
2023-09-30 $66,152,828 443,800
2023-06-30 $62,609,031 464,700
2023-06-30 $102,206,178 758,600
2023-06-30 $2,459,655,127 18,256,180
2023-03-31 $201,730,546 1,265,800
2023-03-31 $43,412,388 272,400
2023-03-31 $3,300,210,370 20,707,852
2022-12-31 $71,334,654 441,400
2022-12-31 $107,777,709 666,900
2022-12-31 $3,229,155,102 19,981,159
2022-09-30 $46,879,553 349,300
2022-09-30 $2,671,572,714 19,905,914
2022-09-30 $59,428,188 442,800
2022-06-30 $76,978,216 502,600
2022-06-30 $46,284,952 302,200
2022-06-30 $3,224,547,776 21,053,459
2022-03-31 $87,669,088 540,800
2022-03-31 $3,219,749,708 19,861,512
2022-03-31 $49,540,816 305,600
2021-12-31 $57,328,360 423,400
2021-12-31 $2,761,452,125 20,394,772
2021-12-31 $101,888,500 752,500

Report a Problem

Category
Description
Email (optional, for follow-up)